Envoy Medical, Inc. (COCH) News
Track canonical SquawkNews coverage tagged to COCH, Envoy Medical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
Envoy Medical Inc. (NASDAQ: COCH ) on Tuesday reported 12-month results from the first 10 participants in Stage 1 of its pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant, wit
CENTRAL_BANK | Jul 14, 2026, 01:01 PM UTC
L
Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval app
Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval application to the FDA for its Breakthrough Device-designated product.
REGULATION | Jun 30, 2026, 05:48 PM UTC
L
Envoy Medical Submits First Module Of Modular Premarket Approval Application To FDA For Breakthrough Device-Designated Product; Co Plans Fou
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027 White Bear Lake, Minnesota--(Newsfile Corp. - June
REGULATION | Jun 30, 2026, 12:45 PM UTC